Roger Adsett is the Chief Operating Officer at Insmed Incorporated (INSMED INC), a global biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare diseases. With a robust background in the biopharmaceutical industry, Adsett has been instrumental in guiding Insmed's operational strategies and enhancing its capabilities to deliver life-changing treatments. Before joining Insmed, Adsett held several key leadership positions in the healthcare sector. He has a proven track record of driving growth and operational excellence, having worked with companies such as Shire Pharmaceuticals and Bausch & Lomb. At Shire, he served as Senior Vice President of Technical Operations, where he was responsible for overseeing global manufacturing, supply chain, and quality assurance. His strategic vision and operational acumen were pivotal in scaling up production and ensuring the timely delivery of critical therapies to patients worldwide. In his current role as COO at Insmed, Roger Adsett is responsible for overseeing the company's manufacturing, supply chain, and quality operations. His leadership has been crucial in navigating the complexities of bringing new drugs to market, particularly in the challenging field of rare diseases. Under his guidance, Insmed has successfully expanded its manufacturing footprint and strengthened its supply chain, ensuring that patients have access to the treatments they need. Adsett's commitment to excellence and innovation continues to drive Insmed's mission to transform the lives of those affected by rare diseases.